TB in Foreign Born and High Risk Populations
|
|
- Jody Lloyd
- 5 years ago
- Views:
Transcription
1 TB Nurse Case Management San Antonio, Texas December 8-10, 2009 TB in Foreign Born and High Risk Populations John J. Nava, M.D. December 9, 2009 Tuberculosis in High Risk Populations and the Foreign Born Nurse Case Management Course Heartland Center December 9, 2009 John J. Nava, M.D. Medical Chief City Chest Clinic San Antonio Metropolitan Health District 1
2 Objectives (1) High risk populations due to recent exposure to active contagious TB case Social conditions that promote transmission Conditions that predispose persons to progress from latent infection to active disease preexisting medical condition acquired states 3 Objectives (2) Newly diagnosed TB cases in the US foreign born vs. US born Historical perspective Compare previous and revised Tuberculosis Component of Technical Instructions for Civil Surgeons Become familiar with countries of origin of newly diagnosed cases in foreign born Challenges of caring for refugees, recent immigrants, legal residents, visitors, students Case studies 4 2
3 Tuberculosis: Not Just a Disease From the Past! Social Conditions That Increase the Risk of TB Disease (1) Overcrowding in high risk congregate settingse.g. correctional facilities, ICE facilities, shelters for the homeless, schools, health care facilities, all for both residents and employees Poor sanitation Poor ventilation Impoverished populations with limited access to health services and limited health literacy 6 3
4 Social Conditions That Increase the Risk of TB Disease (2) Travel to or from areas of the world where TB is prevalent Close contacts to cases of active contagious TB 7 Risk of Developing TB Disease if Infected 5-10% of infected adults with normal immune systems develop TB disease at some point in life HIV strongest risk factor for development of TB disease if infected Risk of developing TB disease 7% to 10% each year Certain medical conditions increase risk that TB infection will progress to TB disease 8 4
5 Medical Conditions That Increase the Risk of Progression to TB Disease (1) HIV infection Substance abuse Co-existing infections Diabetes mellitus Silicosis Prolonged corticosteroid therapy Other immunosuppressive therapy, e.g. TNF-α blockers, anti-rejection meds for transplant recipients, antimetabolites 9 Medical Conditions That Increase the Risk of Progression to TB Disease (2) Cancer of the head and neck Hematological and reticuloendothelial diseases End-stage renal disease Intestinal bypass or gastrectomy Chronic malabsorption syndromes Low body weight (10% or more below the ideal) 10 5
6 Children with Exposure to TB Infants from birth to 1 year of age have the highest risk of developing TB disease upon exposure. Children < 5 years of age require an early and thorough medical evaluation, including a CXR, when exposure is suspected. A child that has TB requires a family and community intervention! 11 Children with TB Infection Most infants and children who develop TB disease Progress within 3-12 months of TB infection. Are prone to rapid progression and more severe forms of TB disease. Contact investigation of adult pulmonary TB cases is crucial to the detection, control and prevention of pediatric TB and its complications. (MMWR Controlling TB in the US, 2005, pg. 43) 12 6
7 Number of TB Cases in U.S.-born vs. Foreign-born Persons United States, * No. of Cases U.S.-born Foreign-born *Updated as of May 20, Trends in TB Cases in Foreign-born Persons, United States, * No. of Cases Percentage 10, , , , , No. of Cases Percentage of Total Cases *Updated as of May 20,
8 Reported TB Cases by Origin and Race/Ethnicity,* United States, 2008 U.S.-born Foreign-born** Asian (3%) American Indian or Alaska Native (3%) Black or African American (42%) White (5%) Asian (43%) White (33%) Native Hawaiian/Other Pacific Islander (<1%) Hispanic or Latino (17%) Hispanic or Black or African Latino (38%) American (14%) *All races are non-hispanic. Persons reporting two or more races accounted for less than 1% of all cases. **American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander accounted for less than 1% of foreign-born cases and are not shown. Reported Tuberculosis in the United States, 2008, Executive Commentary Age as risk factor Highest burden of disease 65 years and older with case rate 6.4 per 100,000 contrasting to children < 14 years with case rate 1.3 per 100,000 Case rates for all age groups either declined or remained constant. Race and ethnicity Hispanics (8.1 from 19.9), African Americans or blacks (8.8 from 28.5), and Asians (highest at 25.6, 3X AA or HA) 16 8
9 TB Case Rates in U.S.-born vs. Foreign-born Persons United States, * Cases per 100, U.S. Overall U.S.-born Foreign-born *Updated as of May 20, TB Case Rates in U.S.-born vs. Foreign-born Persons United States,* ** Ca ases per 100, U.S. Overall U.S.-born Foreign-born *Includes the same data as slide 15, but rates presented on a logarithmic scale. **Updated as of May 20,
10 Countries of Birth of Foreign-born Persons Reported with TB United States, 2008 Other Countries (38%) Mexico (23%) Philippines (11%) Haiti (3%) Guatemala (3%) China (5%) Vietnam (8%) India (8%) Reported Tuberculosis in the United States, 2008, Executive Commentary From 2004 to 2008, top five countries of origin of foreign-born persons with TB were Mexico, Philippines, Vietnam, India, and China Of the 7,563 TB cases reported among foreign-born persons in 2008, 43% among persons born in the Americas region, and 30% among persons born in the Western Pacific region From 1993 to 2008, proportions of cases increased among persons born in the Eastern Mediterranean region (3% to 4.5%), the Southeast Asia region (6% to 13%), and the African region (2% to 8%) These trends reflect the changing resettlement patterns of new arrivals to the US by immigrants and refugees
11 Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, % 80% 60% 40% 20% 0% All Mexico Philippines India Missing* <1 yr 1 4 yrs >5 yrs * Foreign-born TB patients for whom information on length of residence in the U.S. prior to diagnosis is unknown or missing. % Resistant Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons United States, * U.S.-born Foreign-born *Updated as of May 20, Note: Based on initial isolates from persons with no prior history of TB. 11
12 Tuberculosis Case Studies 23 Case 1: CDC Request for evaluation of recent immigrant family (1) 7 year old male from Philippines, urgent B1 TB evaluation, arrived DFW 11/23/09 TBST 11 mm on 11/19/08, no history of TB Rx. 07/15/09 abnormal CXR noted in Manila, asymptomatic Nodular infiltrate RUL with R hilar adenopathy, partial clearing since 11/19/08 Sputum smear and culture negative X 3 on July 22, 23, 24 in
13 Case 1: CDC Request for evaluation of recent immigrant family (2) 12/02/09 presents to City Chest Clinic, with mother and sister TBST replaced, result 10 mm 48 hours later CXR repeated on 12/02/09, parahilar markings increased with fullness of hilar regions, but no focal infiltrate, still asymptomatic CT considered, but no resources, waiting period for Medicaid or CHIP 25 Case 1: CDC Request for evaluation of recent immigrant family (3) 42 year old female from Philippines, urgent B1 TB evaluation, arrived DFW 11/23/09, mother of 7 year old 07/15/09 abnormal CXR noted in Manila, asymptomatic Right apical pleural thickening with infiltrates, but stable since 11/17/08 Sputum smear and culture negative X 3 on July 22, 23, 24 in 2009, and patient reports similar evaluation in November
14 Case 1: CDC Request for evaluation of recent immigrant family (4) Mother had TBST placed and induced sputum collected at City Chest Clinic i on 12/02/09, despite denial of any symptoms of TB (associate investigation for son) TBST result 00 mm at 48 hours Sputum smear few 2+ AFB (1-9 per 10 HPF) RIPE begun on both patients 12/04/09 27 Old versus Revised Technical Instructions for Tuberculosis 1991 Algorithm Sputum smear X 3 required if CXR abnormal and suspicious for active disease No sputum smear required if CXR abnormal but appeared inactive Treat PTB until smear negative, then cleared for travel 28 14
15 1991 Tuberculosis Technical Instructions: for applicants 15 years of age Inactive TB Chest radiograph No TB Class B2 Active TB No Class Valid for travel within 6 months Valid for travel within 12 months Valid for travel within 6 months AFB sputum smears (3) Noninfectious Class B1 All (-) (at least one +) Infectious Class A Treat until smear negative Rationale for Overseas Screening and Domestic Follow-up Overseas Panel Physicians screen TB suspects using DGMQ TIs Restrict entry of infectious TB cases Facilitate entry of the rest to allow U.S.entry, evaluation and treatment per ATS/CDC standards per ATS/CDC standards US Health Department follow-up evaluation and treatment of noninfectious cases is cost-effective 15
16 2007 Technical Instructions: Classifications Class 1991 Technical 2007 Technical Instructions Instructions No Classification Normal evaluation Normal evaluation Class A Tuberculosis disease Tuberculosis disease Class B1- Pulmonary Abnormal CXR, sputum smears negative Abnormal CXR, sputum smears and cultures negative Extrapulmonary tuberculosis Class B1 Et Extrapulmonary Et l Extrapulmonary tuberculosis Class B2 Inactive tuberculosis on LTBI Evaluation CXR Class B3 Old or healed tuberculosis Contact Evaluation Old versus Revised TI s New for May 2008 If CXR abnormal, do sputum smear and add culture and DST CXR for age > 15 years TST for ages 2 to 15 years If PTB, must complete treatment per ATS/CDC guidelines and by DOT, prior to travel to US LTBI treatment recommended for highest risk contacts, such as child < 5, HIV
17 TI Appendix B - Radiographic Findings Suggestive of Active TB Disease Infiltrate or consolidation Any cavitary lesion Nodule with poorly defined margins Pleural effusion Hilar or mediastinal adenopathy Any other finding suggestive of active TB - miliary 33 TI Appendix B - Radiographic Findings Suggestive of Inactive TB Disease Discrete fibrotic scar or linear opacity Discrete nodule(s) without calcification Discrete fibrotic scar with volume loss or retraction Other any other finding suggestive of prior TB, such as upper lobe bronchiectasis (bronchial dilation with bronchial wall thickening) CAUTION : Assessments of the activity of TB disease cannot be made accurately on the basis of a single radiograph. CAUTION : Blunting of the costophrenic angle may be a nonspecific finding in adults. In contrast, a larger pleural effusion suggests active TB disease. CAUTION : In children, even minor blunting of the costophrenic angle suggests active TB disease
18 Reported Tuberculosis in the United States, 2008, Executive Commentary Improve overseas screening of immigrants and refugees by systematically monitoring and evaluating the screening process Strengthen the current notification system that alerts local health departments about the arrival of immigrants or refugees who have suspected TB to enhance the evaluation and treatment of such persons Improve coordination of TB control activities between the United States and Mexico to ensure completion of treatment among TB patients who cross the border Test recent arrivals from high-incidence incidence countries for latent TB infection and monitor treatment completion Survey foreign-born TB patients in the United States to determine opportunities for improving prevention and control interventions 35 Common Barriers to Timely Evaluation Moves after arrival to U S Moves after arrival to U.S. No legal authority to get patients in for screening and evaluation Language/cultural barriers 18
19 Tuberculosis Case Studies 37 Case 2: Delayed B1 TB evaluation with evolving CXR (1) 17 year old recent immigrant from Vietnam, entered US 08/11/09, referred to City Chest Clinic by ICE for B1 TB evaluation. PMH of TB treatment with two drugs for 4 months, starting in April 2009, but no documentation. Also with H/O stomach ulcer in Had recently been seen by grandfather s PCP for stomach pain, resolved with OTC Pepcid and Maalox for two weeks. Patient denied any other symptoms and was looking forward to taking placement test to enter high school, as he had already finished the 12 th grade in Vietnam. CXR showed RUL nodular opacity noted in Ho Chi Minh City on 03/03/09 Collected sputum X 3 on 03/4, 3/5, and 3/16/09, all smear negative and culture negative in Vietnam, cleared to travel 38 19
20 Case 2: Delayed B1 TB evaluation with evolving CXR (2) Reported to City Chest Clinic on 09/28/09, and had TBST placed and repeat CXR ordered, due to the long interval (6 months) since prior film, and no old film to examine. The patient denied all symptoms of TB. CXR showed patchy and interstitial opacities in LUL that may be acute, and suggestion of a 2 cm. cavitary lesion, again suggesting acute disease. Right lung had small oval calcified granuloma. Collected induced sputum on 09/29/09 and ordered two more natural sputum collections at home, and started RIPE by daily DOT for Class 5, TB suspect Smear results subsequently came back <1 AFB on 09/29/09, >10 on 09/30/09, and 1-10 on 10/01/09 39 Case 2: Delayed B1 TB evaluation with evolving CXR (3) Cultures subsequently grew out MTBC, sensitivity ypending Clinical improvement noted, with 3 ½ pound weight gain after one month of RIPE Sputum smear improving with negative on 10/7 (natural), <1 AFB on 10/20 (natural), negative on 10/22 (natural), and <1 on 10/27 (induced) 11/2 through 11/5 received notification Resistant to INH, rifampin, rifabutin, ethambutol, PZA, and ofloxacin 40 20
21 Case 2: Delayed B1 TB evaluation with evolving CXR (4) Sensitive to ethionamide, capreomycin, and dkanamycin 2 nd line drug susceptibility requested for cycloserine, linezolid, moxifloxacin, PAS Initiated process for admission to TCID Now on amikacin, ethionamide, moxifloxacin, cycloserine, PAS, and B
22 The more we Think TB the more likely that cases are diagnosed without delays that lead to increased morbidity and mortality, especially in our children. 43 For Reporting and Consultation San Antonio Metropolitan Health District Chest Clinic 44 22
23 Resources on TB San Antonio Metropolitan Health District - CDC Division of Tuberculosis Elimination - Guidelines Available Online at: CDC s - Morbidity and Mortality Weekly Report - Heartland National TB Center TB Educate TBresources.com 45 23
The Epidemiology of Tuberculosis in Minnesota,
The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available
More informationDiagnosis and Medical Management of Latent TB Infection
Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,
More informationTuberculosis Populations at Risk
Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationTB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012
TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release
More informationTuberculosis in Chicago 2007
City of Chicago Communicable Disease Information Department of Public Health Richard M. Daley, Mayor May 2008 Terry Mason, MD, FACS, Commissioner www.cityofchicago.org/health/ West Side Center For Disease
More informationTB Classification (ATS/CDC)
bits and pieces Lisa Chen, MD UCSF Pulmonary/Critical Care Curry International Tuberculosis Center 10/2017 TB Classification (ATS/CDC) TB0 No tuberculosis exposure, not infected TB1 Tuberculosis exposure,
More informationCase Presentations Part 2
Case Presentations Part 2 Connie A. Haley, MD MPH University of Florida, Infectious Diseases and Global Medicine Megan Ninneman, PA Jackson Memorial Hospital, Miami FL Objectives Demonstrate the ability
More informationTB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology
TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More informationDiagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015
Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationhas the following disclosures to make:
CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash
More informationINDEX CASE INFORMATION
Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.
More informationTB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014
Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationChapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United
More informationTuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)
Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)-750-5496 Local health care providers, including physicians offices, labs and hospitals, are required by law to
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationDIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE
DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case
More informationANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012
ANNUAL TUBERCULOSIS REPORT OREGON 211 Oregon Health Authority Public Health Division TB Program November 212 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-211... page
More informationChapter 5 Treatment for Latent Tuberculosis Infection
Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI
More informationAnnual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
More informationDiagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015
Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationErrors in Dx and Rx of TB
Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a
More informationTuberculosis Epidemiology
Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline
More informationUtilizing All the Tools in the TB Toolbox
Utilizing All the Tools in the TB Toolbox Sandra Morano, B.A., R.N. Public Health Nurse, City of Stamford, CT TB Talk The New England TB Consortium March 18, 2010 Background TB Program, City of Stamford,
More informationPediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017
Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures
More informationSubstance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010
Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Mary Long, MPSH; Heartland Phillip Lindsey, MD; OK State
More informationLatent Tuberculosis Best Practices
Latent Tuberculosis Best Practices Last Updated September 7, 2016 LTBI Demographics in the US o 13million people in the US with LTBI (estimate) o In 2014, approximately 66% of TB cases in the United States
More informationContact Investigation
Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationDiagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011 Lisa Armitige, MD, PhD has the following disclosures to make:
More information2014 Annual Report Tuberculosis in Fresno County. Department of Public Health
214 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally
More informationDisclosures. TB and CoMorbidities Challenges and Opportunities. Burden of TB. Outline of the lecture. Target testing for TB Infection TB HIV 3/25/2012
Disclosures TB and CoMorbidities Challenges and Opportunities E. Jane Carter, M.D. Associate Professor of Medicine Alpert School of Medicine, Brown University Providence, Rhode Island No financial disclosures
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationTB in Prisons and Jails Albuquerque, New Mexico November 28, 2012
TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012 Challenges of TB Treatment in Special Populations in Corrections Marcos Burgos, MD November 28, 2012 Marcos Burgos, MD has the following
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationI. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %
San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population I. Demographic Information Table I-A: TB cases by gender, SJC, 03 (N=43) GENDER NUMBER OF CASES Male 6 60.5% Female 7
More informationHaley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic
Haley Blake Sage Nagai, MPH Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic Discuss the prevalence of tuberculosis in Clark County Describe factors influencing
More informationDiagnosis and Treatment of Tuberculosis, 2011
Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is
More informationLTBI: Who to Test & When to Treat
LTBI: Who to Test & When to Treat TB Intensive May 10 th, 2016 David Horne, MD, MPH Harborview Medical Center University of Washington DISCLOSURES I have no disclosures or conflicts of interest to report
More informationLatent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal
Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal Civil surgeons are required to report tuberculosis (TB) screening outcomes that result in latent TB
More informationTB-Free California: How close are we? How can we get closer?
TB-Free California: How close are we? How can we get closer? California TB Controllers Association April 21, 2015 Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology Section Acknowledgments Local
More informationTB Intensive Minneapolis, Minnesota September 23-26, 2008
TB Intensive Minneapolis, Minnesota September 23-26, 2008 TB in the Foreign-Born Population: Background and Demographic Overview Marge Higgins, LSW September 24, 2008 TB in the Foreign-Born Population
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 Pediatric TB Kim Smith, MD, MPH July 19, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationDiagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017
Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has
More informationCLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease
CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease Barbara J Seaworth MD Medical Director Heartland National TB Center Professor of Medicine University of Texas Health Center Tyler Barbara J Seaworth MD has
More informationAn Introduction to Radiology for TB Nurses
An Introduction to Radiology for TB Nurses Garold O. Minns, MD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Garold O. Minns, MD has the following disclosures
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Epidemiology Robert Petrossian July 18, 2012 Robert Petrossian has the following disclosures to make: No conflict of interests No relevant
More informationContact Investigation and Prevention in the USA
Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis
More informationTUBERCULOSIS CONTACT INVESTIGATION
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationTB Nurse Case Management San Antonio, Texas March 7 9, Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012
TB Nurse Case Management San Antonio, Texas March 7 9, 2012 Pediatric TB Kim Connelly Smith, MD, MPH March 8, 2012 Kim Connelly Smith, MD, MPH has the following disclosures to make: No conflict of interests
More informationTreatment of Tuberculosis, 2017
Treatment of Tuberculosis, 2017 Charles L. Daley, MD National Jewish Health University of Colorado Health Sciences Center Treatment of Tuberculosis Disclosures Advisory Board Horizon, Johnson and Johnson,
More informationThe American Experience with TB Elimination
Reaching the Goal of TB Elimination by 2035 March 3, 2015 The American Experience with TB Elimination John Jereb, M.D. Medical officer Division of Tuberculosis Elimination National Center for HIV/AIDS,
More informationACTIVE TUBERCULOSIS IN MACOMB COUNTY, A Review of TB Program Data,
ACTIVE TUBERCULOSIS IN MACOMB COUNTY, 1996-2010 A Review of TB Program Data, 1996-2010 Prepared by: Janice M. Chang, MBBS, MPH Division Director, Health Promotion and Disease Control Macomb County Health
More informationPediatric TB Lisa Armitige, MD, PhD September 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.
More informationLatent TB, TB and the Role of the Health Department
Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,
More informationTuberculosis in Alameda County, 2009
Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread
More information11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016
Disclosures Update In Tuberculosis, Indiana 2017 Bradley Allen, MD, PhD, FACP, FIDSA Indiana University School of Medicine Division of Infectious Diseases Roudebush VAMC Indianapolis Medical Consultant,
More informationTB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014
TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014 Catalina Navarro, BSN, RN has the following disclosures to make: No conflict of interests No relevant financial relationships with
More informationTreatment of Tuberculosis
TB Clinical i l Intensive Seattle Treatment of Tuberculosis June 16, 2016 Masa Narita, MD Public Health Seattle & King County; Firland Northwest TB Center, University of Washington Outline Unique features
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationAppendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationTreating TB What Happened? All the Patients Have Challenging Co-Morbid Conditions Now!
EXCELLENCE EXPERTISE INNOVATION Treating TB What Happened? All the Patients Have Challenging Co-Morbid Conditions Now! Barbara J Seaworth, MD, Medical Director, Heartland National TB Center Professor,
More informationTB the basics. (Dr) Margaret (DHA) and John (INZ)
TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2
More informationTuberculin Skin Testing
Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 Testing to TB Infection Using the TST Presented by Debra Howenstine, MD for Debbie Onofre, RN October 5, 2010 Tuberculin
More informationEpidemiology of Tuberculosis Denver TB Course
Epidemiology of Tuberculosis Denver TB Course Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver
More informationTherapy for Latent Tuberculosis Infection
Screening and Treatment of LTBI in TB Control in the US Margarita Elsa Villarino MD MPH Division of TB Elimination, CDC April 14, 2004 TB Prevention and Control in the United States The fundamental strategies
More informationAppendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
More informationTuberculosis Intensive November 17 20, 2015 San Antonio, TX
Treatment of Tuberculosis Elizabeth S. Guy, MD November 17, 2015 Tuberculosis Intensive November 17 20, 2015 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Elizabeth S. Guy, MD has the following disclosures
More informationWhat you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013
What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2013 Case 1: 52 y/o male Born in the Pacific Islands; some travel in
More informationLATENT TUBERCULOSIS SCREENING AND TREATMENT:
LATENT TUBERCULOSIS SCREENING AND TREATMENT: TB or not TB Christopher Kwong, MD and William Rifkin, MD Week 14 Educational Objectives: 1. Understand who should be screened for latent TB infection and why
More informationPREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal
PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.
More informationTuberculosis in Chicago 2006
Chicago Department of Public Health May 27 Communicable Disease Information Tuberculosis in Chicago 26 City of Chicago Richard M. Daley, Mayor Department of Public Health Terry Mason, MD, FACS Commissioner
More informationContact Investigation San Antonio, Texas January 14-15, 2013
Contact Investigation San Antonio, Texas January 14-15, 2013 Assigning Priorities to Contacts Patrick Moonan, PhD, MPH January 14, 2013 Patrick Moonan, PhD, MPH has the following disclosures to make: No
More informationTB Radiology for Nurses Garold O. Minns, MD
TB Nurse Case Management Salina, Kansas March 31-April 1, 2010 TB Radiology for Nurses Garold O. Minns, MD April 1, 2010 TB Radiology for Nurses Highway Patrol Training Center Salina, KS April 1, 2010
More informationCase Management of the TB/HIV Infected Patient
TB Nurse Case Management San Antonio, Texas December 8-10, 2009 Case Management of the TB/HIV Infected Patient Sarah Hoffman, MPH, MSN, ACRN December 9, 2009 TB/HIV: Considerations in the Care of the Coinfected
More informationThe Elimination of Tuberculosis. Richard E. Chaisson, MD. Center for TB Research Center for AIDS Research Johns Hopkins University
The Elimination of Tuberculosis Richard E. Chaisson, MD Center for TB Research Center for AIDS Research Johns Hopkins University Disclosures Spouse owns Merck stock Consultant: Merck Research funding:
More informationA look at medical factors that increase the risk for TB disease
A look at medical factors that increase the risk for TB disease Mark Lobato, MD New England TB Consultant Division of Tuberculosis Elimination CDC Overview The spectrum of M. tuberculosis infection Immune
More informationTB Intensive San Antonio, Texas December 1-3, 2010
TB Intensive San Antonio, Texas December 1-3, 2010 TB Case Presentations Doug Hornick, MD; Iowa U Medical School December 1, 2010 Pulmonary Fascinomas with a Tuberculous Attitude Douglas B. Hornick, MD
More informationMoving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012
Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 LTBI and TB Disease Treatment Cara Christ, MD, MS May 8, 2012 Cara Christ, MD, MS has the following disclosures to make: No conflict
More informationInvestigation of Contacts of Persons with Infectious Tuberculosis, 2005
1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control
More informationManaging Complex TB Cases Diana M. Nilsen, MD, RN
Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening
More information5. HIV-positive individuals treated with INH should receive Pyridoxine (B6) 25 mg daily or 50 mg twice/thrice weekly on the same schedule as INH
V. TB and HIV/AIDS A. Standards of Treatment and Management The majority of TB treatment principles apply to persons with HIV/AIDS who require treatment for TB disease. The following points are either
More informationInterpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation.
Diagnostic Evaluation Medical Evaluation & CXR Interpretation University of Michigan TB Consultant Washtenaw County Medical history Physical examination Testing for TB exposure (previously covered) Radiologic
More informationThe Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer
The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System
More informationContracts Carla Chee, MHS May 8, 2012
Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Contracts Carla Chee, MHS May 8, 2012 Carla Chee, MHS has the following disclosures to make: No conflict of interests No relevant
More informationAt the end of this session, participants will be able to:
Advanced Concepts in Pediatric Tuberculosis: Infection Control, Source Case and Contact Investigation Ana M. Alvarez, M.D. Associate Professor Division of Pediatric Infectious Diseases and Immunology University
More informationTreatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015
Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active
More informationTuberculosis Intensive
Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationTuberculosis Education for the Medical Professional
Tuberculosis Education for the Medical Professional North Dakota Diagnosis and Medical Management of Latent TB Infection Dawn Farrell, RN, BSN, PHN Maria Robles, BSN July 10, 2007 Tuberculosis Education
More informationTuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant
Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection
More information